Javascript must be enabled to continue!
Clinical Characteristics of Patients with Urosepsis: A Descriptive Study Based on the MIMIC-IV Database
View through CrossRef
Abstract
Objective
This study aimed to compare the clinical characteristics of urosepsis patients with those having other types of sepsis, extract key clinical insights, and identify potential future research avenues.
Material and Methods
Data from 32,971 anonymized records in the MIMIC-IV database were analyzed. Among these, 6,141 patients met the inclusion criteria for sepsis. A comparative analysis was conducted, followed by univariate and multivariate Cox regression analyses to assess in-hospital mortality.
Results
The analysis included 1,418 urosepsis patients and 4,723 non-urosepsis patients. Urosepsis predominantly affected older individuals, particularly women, with a higher prevalence of comorbidities such as myocardial infarction, congestive heart failure, renal disease, severe liver disease, diabetes mellitus, and AIDS. Laboratory evaluations indicated lower white blood cell counts, neutrophil levels, and neutrophil-to-lymphocyte ratios (NLR) in urosepsis patients. The main pathogens in urosepsis were gram-negative bacteria (44.0%) and fungi (21.9%), whereas non-urosepsis was mainly caused by Gram-positive bacteria (57.2%). Regression analysis showed advanced age and elevated lactate levels as significant predictors of in-hospital mortality in urosepsis. The use of vasoactive agents appeared to improve prognosis. Current SOFA and SAPS II scores are inadequate for evaluating urosepsis severity.
Conclusions
Urosepsis is characterized by a higher prevalence in women, older age, and more comorbidities. Organ failure is less severe than in other sepsis types, resulting in a relatively improved prognosis. Advanced age and elevated lactate levels are independent risk factors, while early vasopressor administration may protect urosepsis patients. Current scoring systems have limited applicability to this population.
Springer Science and Business Media LLC
Title: Clinical Characteristics of Patients with Urosepsis: A Descriptive Study Based on the MIMIC-IV Database
Description:
Abstract
Objective
This study aimed to compare the clinical characteristics of urosepsis patients with those having other types of sepsis, extract key clinical insights, and identify potential future research avenues.
Material and Methods
Data from 32,971 anonymized records in the MIMIC-IV database were analyzed.
Among these, 6,141 patients met the inclusion criteria for sepsis.
A comparative analysis was conducted, followed by univariate and multivariate Cox regression analyses to assess in-hospital mortality.
Results
The analysis included 1,418 urosepsis patients and 4,723 non-urosepsis patients.
Urosepsis predominantly affected older individuals, particularly women, with a higher prevalence of comorbidities such as myocardial infarction, congestive heart failure, renal disease, severe liver disease, diabetes mellitus, and AIDS.
Laboratory evaluations indicated lower white blood cell counts, neutrophil levels, and neutrophil-to-lymphocyte ratios (NLR) in urosepsis patients.
The main pathogens in urosepsis were gram-negative bacteria (44.
0%) and fungi (21.
9%), whereas non-urosepsis was mainly caused by Gram-positive bacteria (57.
2%).
Regression analysis showed advanced age and elevated lactate levels as significant predictors of in-hospital mortality in urosepsis.
The use of vasoactive agents appeared to improve prognosis.
Current SOFA and SAPS II scores are inadequate for evaluating urosepsis severity.
Conclusions
Urosepsis is characterized by a higher prevalence in women, older age, and more comorbidities.
Organ failure is less severe than in other sepsis types, resulting in a relatively improved prognosis.
Advanced age and elevated lactate levels are independent risk factors, while early vasopressor administration may protect urosepsis patients.
Current scoring systems have limited applicability to this population.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Simplified Diagnosis of Urosepsis by Emergency Ultrasound Combined with Clinical Scores and Biomarkers
Simplified Diagnosis of Urosepsis by Emergency Ultrasound Combined with Clinical Scores and Biomarkers
Abstract
Background
Urosepsis is a life-threatening medical condition due to a systemic infection that originates in the urinary...
The Role of Biomarkers and Scores in Describing Urosepsis
The Role of Biomarkers and Scores in Describing Urosepsis
Background and Objectives: Patients with urinary tract obstruction (UTO) and systemic inflammatory response syndrome (SIRS) are at risk of developing urosepsis, whose evolution inv...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Factors associated with urosepsis following percutaneous nephrolithotomy
Factors associated with urosepsis following percutaneous nephrolithotomy
Objective: To evaluate factors associated with urosepsis after percutaneous nephrolithotomy (PCNL). Materials and Methods: Seventy-six upper tract urinary calculi p...
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Pediatric Pilonidal Sinus Disease: A Single-Center Cohort Study of Clinical and Surgical Outcomes
Abstract
Introduction: Pilonidal sinus disease is increasingly recognized in the pediatric population, yet evidence on its clinical characteristics and surgical outcomes in childre...
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
Platform Session B: Clinical Neurophysiology/Clinical Epilepsy
3:00 p.m.–6:00 p.m.
1
Jose F.
Tellez‐Zenteno,
1
Scott B.
Patten, and
1
Samuel
Wiebe
...
AI-infused patients for enhanced clinical simulation
AI-infused patients for enhanced clinical simulation
Artificial intelligence (AI) refers to the simulation of human intelligence in computers, allowing them to perform tasks that usually require human cognitive abilities, such as dec...

